Artax Biopharma's last reported valuation, May 2022. Nothing priced has surfaced since.
- ·Watch Artax Biopharma: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Artax Biopharma funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Early Stage VC | $19.0M | ▮ | ▮ |
| Dec 2021 | Early Stage VC | $25.8M | ▮ | ▮ |
| Feb 2021 | Seed Round | $2.2M | ▮ | ▮ |
| Apr 2020 | Seed Round | $2.0M | ▮ | ▮ |
| Jul 2019 | Seed Round | $750K | ▮ | ▮ |
| Jul 2015 | Seed Round | $3.0M | ▮ | ▮ |
| + 2 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
Artax Biopharma valuation
Artax Biopharma's last reported valuation was $58 million in May 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Artax Biopharma raised?
Artax Biopharma has raised $51.5 million across 8 recorded rounds since 2013. The largest was a $750,000 seed round in Jul 2019; the most recent was a $19 million early-stage round in Jul 2024.
Artax Biopharma has filed 10 Form Ds with the SEC since 2013, most recently in Jul 2025 ($11 million sold to 30 investors).
How Artax Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Artax Biopharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Artax Biopharma
- What is Artax Biopharma worth?
- Artax Biopharma is valued at $58.0M as of Oct 2026. Artax Biopharma's last reported valuation, May 2022. Nothing priced has surfaced since.
- How much has Artax Biopharma raised?
- Artax Biopharma has raised $51.5M in total funding across 8 recorded rounds.
- When did Artax Biopharma last raise?
- Artax Biopharma last raised in Jul 2024 (Early Stage VC), raising $19.0M.